Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 12 | 68158742 | intron variant | -/G;TGAG;TGG;TGTGG;TGTGTGAG;TGTGTGG;TGTGTGTGG | delins |
|
Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Infections; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.742 | 0.320 | 12 | 68156382 | intron variant | A/G;T | snv | 0.50 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Infections | 0.030 | 1.000 | 3 | 2015 | 2019 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2015 | 2015 |